Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Biotechnology    

Global Life Sciences Research Market

PRODUCT TITLE PUBLISHED
European Proteomics European Proteomics
The European Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.28 billion in 2012 and is expected to be $ 7.35 billion by 2018, at a CAGR of 14.6%. The report “European Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Roche, etc.
Upcoming
Asian Proteomics Asian Proteomics
The Asian Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 1.42 billion in 2012 and is expected to be $ 4.16 billion by 2018, at a CAGR of 19.8%. The report “Asian Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Water Corporation, Roche, etc.
Upcoming
Asian Proteomics Instruments Asian Proteomics Instruments
The Asian proteomics market is driven by the increase in the number of diseases and the population suffering from these diseases. The report analyzes the market in terms of product type such protein microarray, spectroscopy, electrophoresis, X-ray crystallography, chromatography, electrophoresis, SPR systems, Protein Fractionation Systems. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, and Water Corporation.  
Upcoming
North America Proteomics Instruments North America Proteomics Instruments
The North American proteomics market is driven by the increase in the number of diseases and the population suffering from these diseases. The report analyzes the market in terms of product type such protein microarray, spectroscopy, electrophoresis, X-ray crystallography, chromatography, electrophoresis, SPR systems, Protein Fractionation Systems. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, and Water Corporation.
Upcoming
European Proteomics Instruments European Proteomics Instruments
The European proteomics market is driven by the increase in the number of diseases and the population suffering from these diseases. The report analyzes the market in terms of product type such protein microarray, spectroscopy, electrophoresis, X-ray crystallography, chromatography, electrophoresis, SPR systems, Protein Fractionation Systems. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, and Water Corporation.    
Upcoming
North American Microfluidics Market North American Microfluidics Market
The North American Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which  was valued at $669 million in 2013 and is poised to grow at a CAGR of  17.4% to reach $1496 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
European Microfluidics European Microfluidics
The European Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which  was valued at $420 million in 2013 and is poised to grow at a CAGR of  15.2% to reach $852 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
Asian Microfluidics Market Asian Microfluidics Market
The Asian Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $369 million in 2013 and is poised to grow at a CAGR of  20.9% to reach $952 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
North American Bio-MEMS Market North American Bio-MEMS Market
The North American  BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others.
Upcoming
European Bio-MEMS Market European Bio-MEMS Market
The European  BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others.
Upcoming
Asian Bio-MEMS Market Asian Bio-MEMS Market
The Asian BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others.
Upcoming
North American High Content analysis/Screening North American High Content analysis/Screening
The North American High Content Screening market was valued at $161.8 million in 2013 and is expected to reach $280.7 million by 2018, growing at a CAGR of 11.7% from 2013 to 2018. High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
European High content analysis/Screening European High content analysis/Screening
The European High Content Screening market was valued at $124.29 million in 2013 and is expected to reach $207.9 million by 2018, growing at a CAGR of 10.6% from 2013 to 2018. High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
Asian High content analysis/Screening Asian High content analysis/Screening
The Asian High Content Screening market was valued at $55.75 million in 2013 and is expected to reach $101.74 million by 2018, growing at a CAGR of 12.8% from 2013 to 2018.High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
North American High throughput screening North American High throughput screening
The North American High Throughput Screening market was valued at $6454.3 million in 2013 and is expected to reach $9046.8 million by 2018, growing at a CAGR of 7.0% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
European High throughput screening European High throughput screening
The European High Throughput Screening market was valued at $3794.7 million in 2013 and is expected to reach $5194.3 million by 2018, growing at a CAGR of 6.5% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
Asian High throughput screening Asian High throughput screening
The Asian High Throughput Screening market was valued at $2547.3 million in 2013 and is expected to reach $3931.2 million by 2018, growing at a CAGR of 9.1% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
North American Proteomics Reagents North American Proteomics Reagents
The North American proteomics reagents market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 1.34 million in 2012, and is expected to reach $ 2.26 billion by 2018, at a CAGR of 8.2%. The report “North American proteomics reagents Market Forecast, 2012-2018”,  analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Sigma- Aldrich Corporation and Bio-Rad laboratories.
Upcoming
European Proteomics Reagents European Proteomics Reagents
The European proteomics reagent market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 1.23 billion in 2012, and is expected to reach $ 2.23 billion by 2018, at a CAGR of 10.3%. The report “European proteomics reagent Market Forecast, 2012-2018”,  analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Bio-Rad laboratories, etc.
Upcoming
Asian Proteomics Reagents Asian Proteomics Reagents
The Asian proteomics reagents market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 541 million in 2012, and is expected to reach $ 12.6 million by 2018, at a CAGR of 15.3%. The report “Asia proteomics reagent Market Forecast, 2012-2018”,  analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies Corporation, Bio-Rad laboratories, Agilent technologies, GE Healthcare, etc.
Upcoming
97 reports | Show
Connect With Us
US/CAN : +1-888-502-0539